ctDNA and MRD in GI Cancers

By Total Health FEATURING Samuel Klempner

718 views

March 1, 2023

Comments 0

ASCO® 2024 Insights: "5-Year Results From the Randomized DYNAMIC Tri…

2024 ASCO® Annual Meeting Insights Hub

J. Tie

552 views

2024 Updates on 1L MSI-H/dMMR mCRC and Using ctDNA MRD Testing in Ea…

Total Health

A. Grothey

488 views

ASCO® 2023 Summary: "GI Expert Panel Discussion on Key Trials Includ…

Insights from 2023 ASCO® Annual Meeting

Y. Janjigian, S. Cytryn, S. Maron

1.6K views

Using ctDNA to Drive Decision Making in Adjuvant Chemotherapy of Col…

Scripps Health

S. Cohen

450 views

ESMO GI 2024 Summary: Combined Analysis of ctDNA and Immunoscore in …

Insights from 2024 ESMO GI Annual Meeting

J. Taieb

277 views

ESMO 2024 Insights: NO-CUT Trial - Total Neoadjuvant Treatment Witho…

ecancer

A. Amatu

170 views

ASCO® 2024 Summary: "Latest Practice-Changing Data in Gastroesophage…

COR2ED The Heart of Medical Education

E. Smyth, S. Klempner, J. Seligmann, D. Modest

192 views

The DYNAMIC Trial: Adjuvant Chemo Guided by ctDNA Analysis in Stage …

PrecisCa

M. Pishvaian

621 views

GI Oncology Year in Review: Key Rectal Cancer Studies PROSPECT & PRO…

Yale Cancer Center

M. Cecchini

222 views

ASCO® GI 2024 Insights: "NRG-GI005 (COBRA) Study - ctDNA as a Predic…

Insights from 2024 ASCO® GI Annual Meeting

V. Morris

300 views

Right Sizing Treatment for Locally Advanced Rectal Adenocarcinoma

City of Hope

A. Barzi

274 views

ESMO GI 2024 Insights: Updates on Treatment of Stage II CRC

Insights from 2024 ESMO GI Annual Meeting

E. Martinelli

128 views

UChicago Medicine Best of ASCO® 2024: CRC

UChicago Medicine Annual Practice Updates in Hematology and Oncology

A. Shergill

90 views

Progress in Colorectal Cancer Treatment With Case Examples

Dana-Farber Cancer Institute

D. Schrag

202 views

ESMO 2023 Panel Discussion: "Lower GI Cancers"

Insights from 2023 ESMO Annual Meeting

S. Cytryn, F. Pietrantonio, G. Argiles Martinez

300 views

ASCO® GI 2024 Insights: "GALAXY Study in CIRCULATE-Japan - Predictin…

Insights from 2024 ASCO® GI Annual Meeting

K. Kaneva

167 views

ESMO 2022 on the NICHE-2 Study: Neoadjuvant Immune Checkpoint Inhibi…

ESMO 2022 Conference Coverage

M. Chalabi

919 views

Case-Based Clinical Updates in GI Cancer: 53 y/o Female With MSI-S C…

Total Health

R. Mehta, M. Tejani, K. Blue

113 views

ESMO 2022 on the HIPECT4 Randomized Phase 3 Study: Adjuvant Hyperthe…